Just days after announcing that it had settled a dispute over ownership of key intellectual property, Alnylam Pharmaceuticals disclosed that it has been sued by the University of Utah over the same IP.

According to an Alnylam filing with the US Securities and Exchange Commission, the university has alleged that one of its researchers, Brenda Bass, is the inventor of the technology covered in the so-called Tuschl-II patent estate.

Alnylam said it disagrees with the claims and intends to “defend the action vigorously.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.